Bill
Bill > A03642
NY A03642
NY A03642Directs the department of health to request guidance from the Centers for Medicare and Medicaid Services to determine whether the state can claim federal financial participation for coverage of and payment for certain prescription digital therapeutics.
summary
Introduced
01/28/2021
01/28/2021
In Committee
05/31/2022
05/31/2022
Crossed Over
Passed
Dead
12/31/2022
12/31/2022
Introduced Session
2021-2022 General Assembly
Bill Summary
Directs the department of health to request guidance from the Centers for Medicare and Medicaid Services to determine whether the state can claim federal financial participation for coverage of and payment for certain prescription digital therapeutics.
AI Summary
This bill directs the New York state Department of Health to request guidance from the Centers for Medicare and Medicaid Services (CMS) to determine whether the state can claim federal financial participation for coverage and payment of certain prescription digital therapeutics (PDTs) approved by the Food and Drug Administration (FDA) to treat substance use and opioid use disorders. The bill aims to accelerate access to these new software-based disease treatments, which are designed to provide evidence-based remote treatment modalities during the COVID-19 pandemic when in-person treatment may be limited.
Committee Categories
Budget and Finance, Health and Social Services
Sponsors (3)
Last Action
substituted by s559 (on 05/31/2022)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.nysenate.gov/legislation/bills/2021/A3642 |
| BillText | https://assembly.state.ny.us/leg/?default_fld=&bn=A03642&term=2021&Summary=Y&Actions=Y&Text=Y&Committee%26nbspVotes=Y&Floor%26nbspVotes=Y#A03642 |
Loading...